Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305676
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-03-06
Brief Title:
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer BASH OPC
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer BASH OPC
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BASH OPC
Brief Summary:
Investigators seek to determine the sensitivity and specificity of a combined HPV 16 DNA and host gene methylation oral biomarker panel to distinguish early Oropharyngeal Cancer OPC cases from controls among 100 early and 100 late disease pre-treatment OPC cases and 200 controls matched by sex age raceethnicity and tobacco use collected from the Moffitt Cancer Center Moffitt and the University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None